Adaptation of Helping Ovarian Cancer Patients Cope (HOPE) for Clinician Burnout (HOPE-C)

What this Trial Is About

Researchers are evaluating an adapted version of the Helping Ovarian Cancer Patients Cope (HOPE) intervention called HOPE-C, designed to address burnout among gynecologic oncology clinicians. Burnout in these clinicians can negatively impact mental health, professional performance, patient outcomes, and healthcare systems. The original HOPE intervention promotes hope in ovarian cancer patients through positive narratives; HOPE-C tailors these concepts to clinicians by fostering peer support and helping them reframe challenging experiences. The study involves three main objectives. First, clinicians review HOPE-C materials and provide feedback through interviews and questionnaires to help develop the intervention. Next, in a pilot trial, clinicians attend four weekly HOPE-C sessions, each lasting about 30 to 45 minutes, focusing on changing narratives, managing uncertainty, and finding meaning. Before and after these sessions, clinicians complete questionnaires. Finally, clinicians may participate in interviews after completing HOPE-C to further optimize and evaluate the intervention. Participants will be involved in reviewing materials, attending sessions, and completing questionnaires and interviews. Researchers will assess feasibility by tracking accrual rates, intervention completion, and survey completion. They will also measure acceptability, satisfaction, and delivery of the intervention. Data collection occurs at enrollment, during the four-week intervention, and up to two weeks post-intervention. The trial is sponsored by Fred Hutchinson Cancer Center and includes clinicians working with ovarian cancer patients.

Adapted Helping Ovarian Cancer Patients Cope Intervention to Address Burnout for Gynecologic Oncology Clinicians